Temperature-Control Solutions Customising the Cold Chain
Of historical global pharmaceutical industry statistics, two in particular stand out. Brazil, Russia, India, and China (BRIC) nations accounted for $2.68bn in sales for 2016, and $8bn was spent on cold chain logistics globally in 2014.
With more diverse temperature demands, the industry is moving away from the term ‘cold chain’ and towards temperature-controlled transport. Drugs contain more high-value active pharmaceutical ingredients (API) and there has been an increase in depend for treatments created using the body’s own substances such as modified cells and blood.
Transit time for such products is a maximum of 36 hours, besides increased requirements for monitoring.
Download this free whitepaper to find out more about the development of the cold chain industry, including innovations inn packaging, drug trends and resulting temperature demands, the cold room solution for air travel, the regulatory environment, and other global concerns.